| scholarly article | Q13442814 |
| P50 | author | Irene Oi-lin Ng | Q67487913 |
| P2093 | author name string | J Wong | |
| C Lau | |||
| S T Fan | |||
| W C Yu | |||
| C M Lo | |||
| R T Poon | |||
| L X Zhu | |||
| P2860 | cites work | High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer | Q74534930 |
| Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation | Q74823576 | ||
| Preoperative chemoembolization of hepatocellular carcinoma: a comparative study | Q74830352 | ||
| Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma | Q77321925 | ||
| Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients | Q77556943 | ||
| Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease | Q77916781 | ||
| Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer | Q77952107 | ||
| Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis | Q34743937 | ||
| Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets | Q35960196 | ||
| Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. | Q36292232 | ||
| Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients | Q36422753 | ||
| Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. | Q36617784 | ||
| Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction | Q36630222 | ||
| Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer | Q38472672 | ||
| Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer | Q38480006 | ||
| Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation | Q40838453 | ||
| Tumor angiogenesis: the pivotal role of vascular endothelial growth factor | Q41111904 | ||
| Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas | Q41256724 | ||
| Constitutive expression of the thrombopoietin gene in a human hepatoma cell line | Q41259944 | ||
| Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres | Q41815837 | ||
| Hepatic resection versus transplantation for hepatocellular carcinoma | Q43946793 | ||
| Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma | Q47866457 | ||
| Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma | Q47912418 | ||
| Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma | Q48032721 | ||
| Serum vascular endothelial growth factor is often elevated in disseminated cancer. | Q48709403 | ||
| Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. | Q50950759 | ||
| Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. | Q53350866 | ||
| Vascular endothelial growth factor serum concentrations in ovarian cancer. | Q53352265 | ||
| Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma. | Q54217111 | ||
| Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma | Q70466366 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract | Q70487576 | ||
| Prognostic value of vascular endothelial growth factor expression in gastric carcinoma | Q71018131 | ||
| Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor | Q71048188 | ||
| Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer | Q71052737 | ||
| Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients | Q71067081 | ||
| Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments | Q71102120 | ||
| Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma | Q71170321 | ||
| Recurrence of hepatocellular carcinoma after surgery | Q71945245 | ||
| Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma | Q72400698 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer | Q72410073 | ||
| Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression | Q73016350 | ||
| Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? | Q73278264 | ||
| Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies | Q73490475 | ||
| Halting angiogenesis suppresses carcinoma cell invasion | Q73851364 | ||
| A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma | Q73894686 | ||
| Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma | Q73908738 | ||
| Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors | Q74452524 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 227-235 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study | |
| P478 | volume | 233 |
| Q92855692 | A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma |
| Q53826807 | A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma. |
| Q35611503 | A decade's studies on metastasis of hepatocellular carcinoma |
| Q42004327 | Accomplishments in 2007 in the management of hepatobiliary cancers. |
| Q35701281 | Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives |
| Q41947562 | Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization |
| Q39439263 | Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. |
| Q57212098 | Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients |
| Q41879721 | Biomarkers and Personalized Sorafenib Therapy |
| Q34256150 | Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy |
| Q53338395 | Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism. |
| Q35133593 | Change in plasma vascular endothelial growth factor after gamma knife radiosurgery for meningioma: a preliminary study |
| Q36012979 | Clinical implications of angiogenesis in cancers |
| Q35165648 | Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches |
| Q37197262 | Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients |
| Q36151194 | Clinicopathological analysis of factors related to colorectal tumor perforation: influence of angiogenesis. |
| Q37719989 | Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma |
| Q34783772 | Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy |
| Q35010945 | Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma |
| Q33241639 | Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma |
| Q90246231 | Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma |
| Q54616826 | Effect of sorafenib on murine liver regeneration. |
| Q41880464 | Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells |
| Q42541191 | Expression of intercellular adhesion molecule-1 in the livers of rats treated with diethylnitrosamine |
| Q36065624 | Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level |
| Q35698574 | HCC and angiogenesis: possible targets and future directions |
| Q44927708 | Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. |
| Q33695543 | Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma |
| Q42476586 | Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma |
| Q26765182 | Hepatocellular carcinoma: Where are we? |
| Q45924805 | High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. |
| Q79886534 | Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma |
| Q46472588 | Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer |
| Q53490169 | Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model. |
| Q39807470 | Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation |
| Q24540058 | Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma |
| Q36739034 | Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma |
| Q81880880 | Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma |
| Q48355658 | Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice |
| Q42172816 | Microvessel density analysis in patients with viral hepatitis-related hepatocellular carcinoma |
| Q34538224 | Moving toward an understanding of the metastatic process in hepatocellular carcinoma |
| Q34953308 | Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials |
| Q92132177 | Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data |
| Q41342988 | Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib |
| Q33867596 | Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres |
| Q36631855 | Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens |
| Q42725868 | Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis |
| Q38410144 | Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound |
| Q39515739 | Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern. |
| Q78052589 | Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation |
| Q78840531 | Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest? |
| Q42460536 | Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study |
| Q57763692 | Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma |
| Q37463744 | Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis |
| Q36067470 | Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q52940263 | Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway. |
| Q37584706 | Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis |
| Q78462843 | Serum endostatin predicts tumor vascularity in hepatocellular carcinoma |
| Q59812312 | Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality |
| Q42727235 | Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center |
| Q79152271 | Significance of circulating endothelial progenitor cells in hepatocellular carcinoma |
| Q35122991 | Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma |
| Q36523547 | Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression. |
| Q34544599 | Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo |
| Q47927563 | The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma |
| Q47654336 | The association between aquaporin-1 expression, microvessel density and the clinicopathological features of hepatocellular carcinoma |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q36409365 | The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma |
| Q38235867 | The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis |
| Q35797957 | Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study |
| Q38217737 | Treating advanced hepatocellular carcinoma: How to get out of first gear |
| Q35010488 | Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma |
| Q28073477 | Understanding the role of PIN1 in hepatocellular carcinoma |
| Q55003892 | VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma. |
| Q80792548 | Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases |
| Q36502592 | Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. |
| Q33723810 | Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma |
| Q36611325 | Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. |
Search more.